Home › Free Stock Grades › WGS
GeneDx Holdings Corp. (WGS) Stock Grade
WGS · Healthcare
C
Market Cap
$2.6B
P/E Ratio
—
Revenue Growth (YoY)
+40.0%
Net Margin
-4.9%
Return on Equity
—
Dividend Yield
None
About GeneDx Holdings Corp.'s fundamentals
GeneDx Holdings is a genomic diagnostics company with a $2.6 billion market capitalization that has demonstrated strong top-line momentum, with revenue growing 40% year-over-year. Despite this robust revenue expansion, the company currently operates at a net loss with a -4.9% net margin, though it maintains positive free cash flow, indicating operational efficiency despite accounting losses. The company does not pay a dividend and offers no earnings per share metric at this time, reflecting its position as a growth-stage diagnostics firm still working toward sustained profitability.